Toby, Eleanor and Callista qualify for Synagis, a 5-dose series of injections containing antibodies that protect high-risk patients from contracting RSV. Their gestational ages and lung complications at birth, their time spent on ventilators, CPAP and oxygen and their family history all lend a hand in qualifying them for this important medication.

They went in for […]